Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

BAZAN, Viviana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 16.366
EU - Europa 7.211
AS - Asia 2.471
AF - Africa 64
SA - Sud America 33
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 12
Totale 26.173
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 16.328
IT - Italia 1.999
FI - Finlandia 1.492
DE - Germania 1.289
CN - Cina 1.178
SG - Singapore 861
UA - Ucraina 704
GB - Regno Unito 386
IE - Irlanda 343
SE - Svezia 279
RU - Federazione Russa 204
BE - Belgio 140
RO - Romania 110
IN - India 96
FR - Francia 94
KR - Corea 82
IR - Iran 54
CI - Costa d'Avorio 44
NL - Olanda 38
TR - Turchia 35
HK - Hong Kong 28
CA - Canada 27
ES - Italia 22
AT - Austria 20
JP - Giappone 19
PK - Pakistan 19
BR - Brasile 16
CH - Svizzera 15
TW - Taiwan 15
AU - Australia 14
EU - Europa 12
CZ - Repubblica Ceca 11
EG - Egitto 11
GR - Grecia 11
PL - Polonia 11
MX - Messico 10
DK - Danimarca 8
UZ - Uzbekistan 8
ID - Indonesia 7
IL - Israele 7
VN - Vietnam 7
AE - Emirati Arabi Uniti 6
BG - Bulgaria 6
LB - Libano 6
TH - Thailandia 6
KZ - Kazakistan 5
LT - Lituania 5
ZA - Sudafrica 5
AR - Argentina 4
CL - Cile 4
EE - Estonia 4
CY - Cipro 3
HU - Ungheria 3
IQ - Iraq 3
MY - Malesia 3
NO - Norvegia 3
PE - Perù 3
PH - Filippine 3
SA - Arabia Saudita 3
AL - Albania 2
BD - Bangladesh 2
BY - Bielorussia 2
CO - Colombia 2
EC - Ecuador 2
KH - Cambogia 2
LK - Sri Lanka 2
LY - Libia 2
MK - Macedonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
AM - Armenia 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
CR - Costa Rica 1
GE - Georgia 1
HR - Croazia 1
IM - Isola di Man 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MC - Monaco 1
MD - Moldavia 1
ME - Montenegro 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
UG - Uganda 1
Totale 26.173
Salva come PNG Salva come JPEG
Città #
Fairfield 2.440
Ashburn 1.542
Chandler 1.393
Woodbridge 1.349
Houston 1.108
Wilmington 1.096
Ann Arbor 1.055
Seattle 951
Cambridge 790
Singapore 717
Palermo 531
Jacksonville 373
Dublin 336
Medford 333
Nanjing 251
Des Moines 242
Princeton 215
Altamura 206
New York 204
Lawrence 175
San Diego 163
Santa Clara 142
Brussels 139
Boardman 132
Dearborn 120
Tulsa 110
Ludwigshafen am Rhein 105
Rome 103
Beijing 98
Milan 79
Shenyang 79
Jinan 78
Seongnam 70
Helsinki 69
Nanchang 65
Kitzingen 62
Venice 61
Hebei 60
London 58
Bremen 55
Kumar 55
Changsha 54
Tianjin 54
Munich 52
Jiaxing 45
Phoenix 45
Abidjan 44
Guangzhou 41
Los Angeles 40
Tehran 37
Ningbo 36
Saint Petersburg 36
Falls Church 35
San Mateo 34
Verona 33
San Paolo di Civitate 32
Auburn Hills 30
Izmir 29
Redwood City 25
Zhengzhou 25
Kilburn 22
Norwalk 22
Columbus 20
Hangzhou 20
Kunming 20
Taiyuan 20
Chicago 18
Pune 18
Washington 17
Taizhou 16
Haikou 15
Volla 15
Dallas 14
Frankfurt am Main 14
Fuzhou 14
Orange 14
Hanover 13
Moscow 13
Lanzhou 12
Tappahannock 12
Toronto 12
Lancaster 11
Atlanta 10
Milazzo 10
Shanghai 10
Tokyo 10
Central 9
Edinburgh 9
Hefei 9
Hong Kong 9
Mascalucia 9
Messina 9
Groningen 8
Lappeenranta 8
Madrid 8
Mazara del Vallo 8
Melfi 8
Padova 8
Vienna 8
Aversa 7
Totale 18.446
Salva come PNG Salva come JPEG
Nome #
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment 279
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 276
EGFR inhibition in NSCLC: New findings…. and opened questions? 254
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus. 222
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 216
Dietary restriction: could it be considered as speed bump on tumor progression road? 212
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. 205
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 205
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 203
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 202
Founder mutations in BRCA1 and BRCA2 genes 201
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 201
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 200
One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients 195
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 194
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 193
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 191
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 191
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 189
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. 188
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 185
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 181
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 181
Anti-endothelin drugs in solid tumors 180
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 180
Apoptosis: a relevant tool for anticancer therapy. 179
A headlight on liquid biopsies: a challenging tool for breast cancer management 179
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. 174
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 173
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 172
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 170
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 170
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 169
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells 169
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 167
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 166
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 165
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 165
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. 165
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 164
Nintedanib in NSCLC: Evidence to date and place in therapy 164
Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy 163
The role of Aurora-A inhibitors in cancer therapy. 163
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 163
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 163
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 162
Monoclonal antibodies in gastrointestinal cancers 162
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 161
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 160
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 160
Targeting apoptosis in solid tumors: the role of bortezomib from preclinical to clinical evidence. 159
Breast cancer genome-wide association studies: there is strength in numbers 158
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? 158
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 158
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations 157
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin. 154
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 154
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 154
The comparison of outcomes from tyrosine kinase inhibitor monotherapy in second- or third-line for advanced non-small-cell lung cancer patients with wild-type or unknown EGFR status 154
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 153
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 152
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. 151
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 151
Laser Pressure Catapulting (LPC): Optimization LPC-System and Genotyping of Colorectal Carcinomas 150
Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors 150
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 150
Beyond evidence-based data: Scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma 150
Q356R and S1512I are BRCA1 variants that may be associated with breast cancer in a Sicilian family. 149
Is BRCA1-5083del19, identified in breast cancer patients of Sicilian origin, a Calabrian founder mutation? 149
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 149
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 149
Ductal lavage: a valid method of risk assessment and of early diagnosis in breast cancer. 147
BRCA1/BRCA2 genes mutational screening in Sicilian breast and/or ovarian cancer families. 145
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. 145
High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability. 145
Ductal lavage: a way of carefully tracing the breast-secreting duct 145
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 144
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 143
The diagnostic accuracy of circulating tumor DNA for the detection of EGFR-T790M mutation in NSCLC: a systematic review and meta-analysis 143
miR-20b Modulates VEGF Expression by Targeting HIF-1a and STAT3 in MCF-7 Breast Cancer Cells 142
VUS variants in BRCA genes of hereditary breast/ovarian cancer 141
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy 141
Monoclonal antibodies for the treatment of non-haematological tumours: Update of an expanding scenario 140
Can KRAS and BRAF mutations limit the benefit of liver resection in metastatic colorectal cancer patients? A systematic review and meta-analysis 140
TP53, H-K-RAS, P16INK4A GENE MOLECULAR ANALYSIS IN SALIVARY GLAND TUMORS 139
Baseline plasma levels of soluble PD-1, PD-L1, and BTN3A1 predict response to nivolumab treatment in patients with metastatic renal cell carcinoma: a step toward a biomarker for therapeutic decisions 139
Analysis of TP53, Ki-Ras and P16INK4A promoter methylation as potential prognostic factors in patients with colorectal cancer 138
Immunotherapy for recurrent ovarian cancer: a further piece of the puzzle or a striking strategy? 138
Programmed Death Ligand 1 (PD-L1) as a Predictive Biomarker for Pembrolizumab Therapy in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC) 138
P16 ink4A, p53 alterations and S phase fraction are predictive of clinical outcome in laryngeal squamous cell carcinoma. 137
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) 137
Looking for the best immune-checkpoint inhibitor in pre-treated NSCLC patients: An indirect comparison between nivolumab, pembrolizumab and atezolizumab 136
Hereditary ovarian cancer 134
BRCA1 germline mutations in Sicilian breast and/or ovarian cancer families and their implications for genetic counselling. 133
Driver mutations and differential sensitivity to targeted therapies: a new approach to the treatment of lung adenocarcinoma 133
The molecular changes driving the carcinogenesis in Barrett's esophagus: Which came first, the chicken or the egg? 133
GENOTYPE ANALYSIS OF COLORECTAL CARCINOMAS THROUGH LASER PRESSURE CATAPULTING (LPC) 132
Genotype analysis of colorectal carcinomas through laser pressare catapulting (LPC) 132
TP53 in gastric cancer: mutations in the l3 loop and LSH motif DNA-binding domains of TP53 predict poor outcome 132
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell 130
Totale 16.523
Salva come PNG Salva come JPEG
Categoria #
all - tutte 105.555
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 105.555
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.470 0 0 0 0 0 735 609 426 550 378 569 203
2020/20213.554 199 249 194 319 421 154 263 254 420 392 363 326
2021/20223.121 217 680 89 127 158 122 200 146 290 376 259 457
2022/20233.972 432 755 97 478 434 594 218 289 413 30 173 59
2023/20242.053 85 245 141 164 128 411 239 241 21 71 23 284
2024/20251.777 104 356 384 438 263 232 0 0 0 0 0 0
Totale 27.283